1.Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity.
Ke-Tai GUO ; Xin-Rui YAN ; Guo-Jin HUANG ; Chun-Xiao XU ; Ying-Shuang CHAI ; Zhi-Qing ZHANG
Chinese Journal of Biotechnology 2003;19(6):730-733
Human tumor necrosis factor alpha (hTNF-alpha) is one of the most important inflammatory cytokines that acts as a mediator in inflammatory and immune response and plays a key role in host defense against infection. The over expression of hTNF-alpha is associated with serious consequences, such as shock, hypotension, thrombus, septicemia and even death. It has been implicated in many autoimmune and inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, chronic heart failure and septic shock. Inhibiting the bio-activity of hTNF-alpha is one of the strategy for the treatment of these diseases. Compared with traditional recombinant protein drugs, small molecule drugs have many advantages, such as high affinity, low immunogenecity and low cost. Systematic evolution of ligands by exponential enrichment (SELEX) is a powerful method for the selection of oligonucleotides that bind with high affinity and specificity to target proteins. Such oligonucleotides are called aptamers, and are potential therapeutics for blocking the activity of pathologically relevant proteins. To obtain oligonucleotide aptamers specifically binding to TNF, a 40nt random DNA combinatorial library flanked by 31nt fixed sequences was chemically synthesized. The random library was amplified with PCR and subjected to selection by SELEX protocol against hTNFalpha. After incubation of the library with hTNFalpha, the mixture was blotted onto Immobilon-NC transfer membrane. The no-specific binding was washed away and the hTNFa binding aptamers were eluted and detached from the target protein. The eluted oligo nucleotides were amplified with PCR and served as the DNA library for the next round selection. After 12 rounds of such selection, the selected aptamers were cloned to pGEM-T vector. Positive clones were identified by restriction enzyme digestion and DNA sequencing. Oligo DNA were synthesized according to the sequence data and tested for their activities. Binding activity of the aptamers to hTNFalpha were detected by ELISA and dot blot with biotin-streptavidin-horseradish peroxidase system. Mouse L929 cells were used to test the anti-hTNFa activity of the DNA aptamers. The aptamers were incubated with hTNFalpha and added to the L929 cells. The results were read under microscope and with MTT staining. It was shown that these DNA aptamers bound to hTNFalpha with high affinity, and can inhibit the cytotoxicity of hTNFalpha on cell culture. The affinity of these aptamers are different and may related to their structure. These ssDNA aptamers are potential for the treatment and diagnosis of hTNFalpha related diseases.
Animals
;
Aptamers, Nucleotide
;
chemical synthesis
;
chemistry
;
genetics
;
pharmacology
;
Biotin
;
chemistry
;
Cell Line
;
Cell Survival
;
drug effects
;
Enzyme-Linked Immunosorbent Assay
;
Gene Library
;
Humans
;
Mice
;
Protein Binding
;
SELEX Aptamer Technique
;
methods
;
Tumor Necrosis Factor-alpha
;
antagonists & inhibitors
;
metabolism
;
toxicity
2.Construction, expression and bioactivity characterization of targeting toxin DT-VEGF.
Ying-Shuang CHAI ; Xin CHENG ; Li-Hong YAO ; Ai-Jun CHEN ; Hong YU ; Xin-Rui YAN ; Run-Qing JIA ; Guo-Jin HUANG ; Zhi-Qing ZHANG
Chinese Journal of Biotechnology 2004;20(2):192-196
Tumor rapid growth depends on neovascularization. Vascular endothelial growth factor, the main mediator during the occurrence and formation of vascularization, has specific receptors whose expression rate shows difference of orders of magnitude between tumor and the normal tissue, so it can be used to transport toxin molecules to the proliferative tumor endothelial and kill cancer cells. In our experiment, we constructed fusion protein DT-VEGF by linking diphtheria toxin's forward 389 amino acids's gene and VEGF165 via a linker. DT-VEGF is expressed in E. coli and purified. Our experiment proves in can kill vascular endothelial cells specifically, and the inhibition of neovascularization of chicken chorionic membrane is also confirmed.
Angiogenesis Inhibitors
;
biosynthesis
;
Diphtheria Toxin
;
biosynthesis
;
genetics
;
Escherichia coli
;
genetics
;
metabolism
;
Genetic Vectors
;
Humans
;
Immunotoxins
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
Vascular Endothelial Growth Factors
;
biosynthesis
;
genetics
3.Role of baicalin in regulating Toll-like receptor 2/4 after ischemic neuronal injury.
Hui-Ying LI ; Zhi-Yi YUAN ; Yu-Gang WANG ; Hong-Jiao WAN ; Jun HU ; Yu-Shuang CHAI ; Fan LEI ; Dong-Ming XING ; Li-Jun DU
Chinese Medical Journal 2012;125(9):1586-1593
BACKGROUNDBaicalin has a significant anti-inflammation effect and is widely used in the clinical treatment of stroke. Most of the studies of Toll-like receptor 2/4 (TLR2/4) during cerebral ischemia had defined their specific expressions in microglia in hippocampus tissue. To explore the targets of baicalin in stroke, we detected the expressions of TLR2/4 in vitro/vivo.
METHODSBy constructing a cerebral ischemia-reperfusion model in vivo and glucose oxygen deprivation model, we successfully induced neuron damage, then added baicalin and detected expressions of TLR2/4, nuclear factor-kB (NF-kB), tumor necrosis factor-alpha (TNFα), and interleukin-1β (IL-1β) in mRNA level and protein level.
RESULTSWe found distinct upregulations of TLR2/4 and TNFα in both mRNA level and protein level in PC12 cells and primary neurons. Moreover, TLR2/4 and TNFα expressions were significantly higher in mice hippocampus treated with cerebral ischemia-reperfusion. Baicalin could downregulate the expressions of TLR2/4 and TNFα in the damaged cells and mice hippocampus effectively.
CONCLUSIONSNeurons could respond to the damage and activate the related signal pathway directly. TLR2/4 responsed to the damage and sent the signal to downstream factor TNFα through activating NF-kB. Baicalin could inhibit the inflammatory reaction in neuron damage and TLR might be its targets, which explained why baicalin could widely be used in the clinical treatment of stroke.
Animals ; Brain Ischemia ; drug therapy ; genetics ; metabolism ; Cells, Cultured ; Female ; Flavonoids ; therapeutic use ; Interleukin-1beta ; genetics ; metabolism ; Male ; Mice ; Mice, Inbred ICR ; NF-kappa B ; genetics ; metabolism ; Neurons ; drug effects ; metabolism ; PC12 Cells ; Rats ; Reperfusion Injury ; drug therapy ; genetics ; metabolism ; Toll-Like Receptor 2 ; genetics ; metabolism ; Toll-Like Receptor 4 ; genetics ; metabolism ; Tumor Necrosis Factor-alpha ; genetics ; metabolism
4.Reproductive toxicity of brazilein in ICR mice.
Zhi-Yi YUAN ; Fan LEI ; Yu-Shuang CHAI ; Hao WU ; Shuang ZHAO ; Yu-Gang WANG ; Tian-Shi FENG ; Hui-Ying LI ; Hui-Yu LI ; Hong-Lei ZHAN ; Dong-Ming XING ; Li-Jun DU
Chinese Journal of Natural Medicines (English Ed.) 2016;14(6):441-448
Brazilein is an active small molecular compound extracted from Caesalpinia sappan L. with favorable pharmacological properties on immune system, cardiovascular system, and nervous system. C. sappan has been used as a traditional medicine in China for hundreds of years for various diseases. However, the general reproductive toxicity of brazilein is still unknown. The purpose of the present study was to thoroughly evaluate the general reproductive toxicity of brazilein in ICR mice to support the future drug development and modernization of this potent traditional Chinese medicine. The results showed that, although no apparent toxicity on the reproducibility of the male was observed, brazilein might cause considerable risks to the fetuses and females as indicated by the ratios of dead fetuses and reabsorptions. In conclusion, our results from the present study provided some useful insights about the safety profile of brazilein, suggesting that brazilein should be used with caution in pregnant women.
Animals
;
Benzopyrans
;
toxicity
;
Caesalpinia
;
toxicity
;
Drugs, Chinese Herbal
;
toxicity
;
Female
;
Indenes
;
toxicity
;
Male
;
Mice
;
Mice, Inbred ICR
;
Pregnancy
;
Reproduction
;
drug effects